AccuTOX-Reprogrammed Mesenchymal Stromal Cells (ARM-X): An Alternative Cellular Vector for Cancer Immunotherapy
Time: 4:00 pm
day: Conference Day One
Details:
- Reprogramming mesenchymal stromal cells in individualized cancer vaccines to present antigens to the immune system
- Employing a fast design and manufacture method of personalized cancer vaccines that is applicable to many indications for effective tumor control
- Unearthing the use of cancer vaccines with checkpoint inhibitors for hard-to-treat cancers
